Tim Schmidt
Chief Development Officer at SENISCA
Tim is SENISCA's Chief Development Officer. With 17+ years of drug development experience, Tim has previously held positions in both pharma (GSK, UCB) and biotech (TxCell, Sitryx), where he successfully led the conception and implementation of translational and early clinical development strategies, leading to the progression of several new therapeutic entities into Ph1 and 2 clinical trials.
Visit website: https://www.senisca.com/#the-team/#tim
See also: 
SENISCA
- University of Exeter spinout developing senotherapeutic interventions through modulation of dysregulated RNA splicing
Details last updated 13-Jan-2024
Tim Schmidt is also referenced in the following:
SENISCA
University of Exeter spinout developing senotherapeutic interventions through modulation of dysregulated RNA splicing
